Clinical Trials Logo

Vision Disorders clinical trials

View clinical trials related to Vision Disorders.

Filter by:

NCT ID: NCT05135195 Completed - Glaucoma Clinical Trials

A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training

Start date: October 24, 2021
Phase: N/A
Study type: Interventional

In this study, the study team utilize virtual reality (VR) to simulate visual impairments of different types and severity in healthy subjects. The platform implements three of the most widespread forms of visual impairment in the United States (US): age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma, each with three levels of severity, (mild, moderate, and severe). At present, glaucoma is further developed toward a multidimensional visual impairment simulation. The platform is utilized: i) to provide a safe, controllable, and repeatable set of environments for development and preliminary testing of electronic travel aids (ETAs) in a variety of conditions (i.e., using the ETA to navigate in the immersed environment); and ii) to equip blind and low vision (BVI) professionals, inclusive of orientation and mobility (O&M) instructors, with a controlled, tunable training platform for skill/capacity building, assessment, and refinement of O&M techniques, as well as visually impaired trainees with a safe and immersive environment to improve their O&M skills and learn novel techniques. Two sets of hypothesis-driven experiments are proposed to assess the feasibility of the platform with respect to these two objectives.

NCT ID: NCT05102955 Completed - Cerebral Palsy Clinical Trials

Turkish Validity and Reliability of the Visual Function Classification System (VFCS)

Start date: November 1, 2021
Phase:
Study type: Observational [Patient Registry]

Cerebral Palsy (CP) is the most common childhood disorder that occurs with a lesion in the developing infant brain, seen in 2-3/1000 live births. CP is a posture, movement and tone disorder that occurs due to prenatal or postnatal causes. It is not progressive, but since the anatomy of the lesion and the physical development of the individual are not completed, the course of the disorder may vary throughout life. Accompanied by motor dysfunctions, it varies according to clinical types. In addition to this, various visual, sensory and behavioral problems, speech disorders that cause learning difficulties and cognitive problems can also be observed. Ophthalmic disorders are the most common problem in CP and can also affect the developmental process of the patient. Since ophthalmic disorders and neurological deficits are associated in CP, the relationship between neurological disorder and ophthalmic disorders has been investigated in the literature. The aim of this study is to establish the Turkish validity and reliability of the Visual Function Classification System (VFCS) specific to individuals with Cerebral Palsy (CP).

NCT ID: NCT05070767 Completed - Headache Clinical Trials

Neurolens Headache Study

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

To understand the benefits of the neurolens Measurement Device and neurolens treatment as it pertains to treating symptoms related to Chronic Headaches. It is a Prospective randomized double masked two arm performed on a minimum of 200 to a maximum of 300 subjects identified as symptomatic (HIT-6 questionnaire score equal to or greater than 56) done across 3-15 clinical sites. There are two subgroups: a minimum of 100 in each subgroup (subgroup 1: pre-presbyopic (18-40 years); subgroup 2: presbyopic subjects (41-60 years).

NCT ID: NCT05016414 Completed - Clinical trials for Space Flight Associated Neuro-ocular Syndrome

Countermeasures for Visual Impairment in Astronauts

STOP-VIIP
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

This study is being done to prevent changes in the vision of astronauts during prolonged residence on the International Space Station or a mission to Mars. This project will provide data about the efficacy of lower body negative pressure to mimic daily upright posture by intermittently lowering central venous pressure while in simulated microgravity (3 days of bed rest). The investigators expect that 3 days of bed rest will increase choroid thickness, and choroid area. The investigators hypothesize that nightly LBNP (-20mmHg) will prevent these changes.

NCT ID: NCT04907955 Completed - Visual Impairment Clinical Trials

Visual Performance Following Implantation of Presbyopia Correcting IOLs

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The purpose of the current study was to compare the visual performance after bilateral implantation of the Panoptix IOL , or the AT LISA IOL or Tecnis Symfony IOL . The focus was on intermediate vision, defocus curves, and contrast sensitivity.

NCT ID: NCT04836715 Completed - Healthy Clinical Trials

Prevalence of Visual Dysfunction in Neurological Disorders

Start date: January 10, 2021
Phase:
Study type: Observational

The objective is to determine the prevalence of visual dysfunction in People with Parkinson's Disease (PwP). The investigators will administer the: Visual Impairment in Parkinson's Disease Screen and Revised-Self-Report Assessment of Functional Visual Performance. Patients seen at Fixel Institute and their caregivers will be invited to participate. Responses to the 2 questionnaires will help determine prevalence rates of visual dysfunction in PwP compared to those both with and without other neurological conditions.

NCT ID: NCT04820218 Completed - Myopia Clinical Trials

At-home Testing Refraction Results With Best Corrected Visual Acuity (BCVA) Outcomes in Adults

Start date: April 21, 2021
Phase: N/A
Study type: Interventional

This study is aimed at examining the BCVA from try-on glasses constructed from measurements from the EyeQue VisionCheck.

NCT ID: NCT04638660 Completed - Clinical trials for Dim Light Vision Disturbances

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

Start date: December 30, 2020
Phase: Phase 3
Study type: Interventional

The objectives of this study are: - To evaluate the efficacy of Nyxol to improve mesopic low contrast visual acuity (mLCVA) in subjects with Dim Light Vision Disturbances (DLD) - To evaluate efficacy of Nyxol to improve visual performance - To evaluate the safety of Nyxol

NCT ID: NCT04516278 Completed - Clinical trials for Diabetic Macular Edema

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Start date: October 1, 2020
Phase: Phase 3
Study type: Interventional

The study will evaluate the safety of ophthalmic bevacizumab in subjects diagnosed with a retinal condition that would benefit from treatment with intravitreal injection of bevacizumab, including: exudative age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion.

NCT ID: NCT04498637 Completed - Disability Physical Clinical Trials

Attitudes Towards Disability of Nursing and Physiotherapy Students

Start date: September 1, 2017
Phase:
Study type: Observational

The general objective of this study is to know the attitude towards people with disability of Nursing and Physiotherapy students in the University of Cadiz. This is a descriptive, correlational, transversal and synchronous study.